red cell folate (level)No significant differenceintervention: 907.0 ±192.8 nmol/L, control: 839.4 ±142.4 nmol/L, p = 0.0095
and higher levels of red cell folate (intervention: 907.0 ±192.8 nmol/L, control: 839.4 ±142.4 nmol/L, p = 0.0095)
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:unmetabolized folic acid (plasma level)No significant differenceintervention: 0.73 nmol/L, control: 1.15 nmol/L, p<0.0001
Infants receiving formula containing L-5-methyltetrahydrofolate had lower mean plasma levels of unmetabolized folic acid (intervention: 0.73 nmol/L, control: 1.15 nmol/L, p<0.0001)
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:Overall tolerabilityReported
Both formulae were well accepted without differences in tolerance or occurrence of adverse events.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:common coldReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:dry skinReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:eczemaReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:poor weight gain or growthReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:rashReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:respiratory tract infectionReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula: